What treatment options are available for a male with hypogonadism (low total testosterone level of 40nmol), elevated Follicle-Stimulating Hormone (FSH) level of 10.5, and normal sperm count?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Approach for This Patient

This patient should NOT receive testosterone replacement therapy and instead requires gonadotropin therapy (hCG plus FSH) if fertility preservation is desired, or lifestyle modifications if fertility is not a concern. 1

Critical Diagnostic Interpretation

Your patient's laboratory values reveal a complex picture that fundamentally changes the treatment approach:

  • Total testosterone of 40 nmol/L (approximately 1,154 ng/dL) is actually NORMAL, not low - the reference range for total testosterone is typically 300-1,000 ng/dL, and this patient's level is at the upper end of normal or slightly elevated 1

  • The elevated SHBG of 95 nmol/L is the key finding - this binds testosterone and may reduce bioavailable testosterone, potentially explaining any symptoms despite normal total testosterone 1

  • FSH 10.5 and LH 7.7 are both in the normal-to-high range, suggesting the hypothalamic-pituitary-gonadal axis is functioning appropriately and attempting to compensate 1

  • Normal sperm count confirms preserved fertility, which is an absolute contraindication to testosterone therapy 1

Why Testosterone Therapy is Contraindicated

The European Association of Urology explicitly recommends against testosterone therapy in eugonadal men (those with normal testosterone levels), even if symptomatic, and specifically for men seeking fertility preservation. 1

  • Testosterone replacement therapy will suppress the hypothalamic-pituitary-gonadal axis, causing azoospermia and infertility 1

  • This patient does not meet diagnostic criteria for hypogonadism, which requires morning total testosterone <300 ng/dL (10.4 nmol/L) on two separate occasions plus specific symptoms 1

  • The FDA labeling for testosterone products specifically states they are "used to treat adult males who have low or no testosterone due to certain medical conditions" - this patient does not qualify 2

Appropriate Treatment Options

If Fertility Preservation is Important:

Gonadotropin therapy (recombinant hCG plus FSH) is the only appropriate hormonal intervention if this patient has symptoms and desires fertility. 1

  • This approach stimulates endogenous testosterone production without suppressing spermatogenesis 1, 3

  • Combined hCG and FSH therapy provides optimal outcomes for maintaining fertility while addressing potential symptoms 1

If Symptoms Exist Despite Normal Total Testosterone:

Address the elevated SHBG through lifestyle modifications first: 1

  • Weight loss through low-calorie diets can improve testosterone bioavailability in men with obesity-associated hormonal issues 1

  • Regular physical activity and exercise should be strongly encouraged, as this can reduce SHBG levels 1

  • Consider evaluating for conditions that elevate SHBG: hyperthyroidism, liver disease, or medications (anticonvulsants, estrogens) 1

Monitoring Approach:

  • Measure free testosterone by equilibrium dialysis to determine if bioavailable testosterone is truly low despite normal total testosterone 1

  • If free testosterone is confirmed low with persistent symptoms, this represents a unique clinical scenario where the elevated SHBG is the primary problem, not testosterone production 1

Critical Pitfall to Avoid

Do not initiate testosterone therapy based on symptoms alone without confirmed biochemical hypogonadism (total testosterone <300 ng/dL). 1 This patient's total testosterone of 40 nmol/L (1,154 ng/dL) is well above this threshold, making testosterone therapy both inappropriate and potentially harmful, particularly given the preserved fertility.

References

Guideline

Testosterone Injection Treatment for Male Hypogonadism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.